Peering Into ZyVersa Therapeutics's Recent Short Interest

ZyVersa Therapeutics's (NYSE:ZVSA) short percent of float has fallen 96.61% since its last report. The company recently reported that it has 15 thousand shares sold short, which is 2.06% of all regula

BenzingaMay 21 15:15 ET

Express News | Zyversa Therapeutics: Inflammasome Asc Inhibitor Ic 100's Preclinical Program Nearing Completion, Glp Toxicology Studies Expected to Begin H1-2024

ReutersMay 15 08:38 ET

Express News | ZyVersa Therapeutics Q1 2024 Adj EPS $(4.53) Misses $(3.70) Estimate

BenzingaMay 15 08:37 ET

Express News | Zyversa Therapeutics Qtrly Shr Loss $4.53

ReutersMay 15 08:37 ET

ZyVersa Therapeutics 1Q Loss/Shr $4.53 >ZVSA

ZyVersa Therapeutics 1Q Loss/Shr $4.53 >ZVSA

Dow JonesMay 15 08:36 ET

Express News | Zyversa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update

ReutersMay 15 08:35 ET